Modifying and optimizing a new era of glaucoma surgeries

Podcast

Oluwatosin U. Smith, MD, Glaucoma Associates of Texas, offers an update on optimization and surgical modifications of newer glaucoma surgeries in preop and postop settings.


Watch this interview: Optimizing and modifying new glaucoma surgeries

Listen to more EyePod episodes

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Related Content
Iantrek announces 1-year clinical results of its bio-interventional technology for uveoscleral outflow enhancement in open-angle glaucoma patients

Iantrek announces 1-year clinical results of its bio-interventional technology for uveoscleral outflow enhancement in open-angle glaucoma patients

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Treating meibomian gland dysfunction and glaucoma

Treating meibomian gland dysfunction and glaucoma

Article
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Podcast
The world's first whole-eye and partial-face transplant recipient continues recovery with viable eye 1 year after landmark surgery

The world's first whole-eye and partial-face transplant recipient continues recovery with viable eye 1 year after landmark surgery

Article
Trinity team’s gene therapy offers promise for treating glaucoma – as well as AMD

Trinity team’s gene therapy offers promise for treating glaucoma – as well as AMD

Article
© 2024 MJH Life Sciences

All rights reserved.